Membership

Coulter Partners Top hires for VC & PE portfolio companies Q1-2025

Recent top global hires for Venture Capital and Private Equity portfolio companies, covering a broad range of disciplines and sectors across Life Sciences, Health and Tech.

This quarter’s successful placements include:

FunctionFocus areaLocation
CEOExosome technologiesItaly
CEOCROFrance
CEOCell & gene therapy toolsUK
Chief Development OfficerCell reprogrammingSweden
Chief Financial OfficerAntibody-drug conjugatesGermany/ US
Chief Business OfficerSmall molecule therapeuticsSwitzerland/ US
Chief Scientific OfficerAI platform technologiesUK
Chief Commercial OfficerCDMOUK
Chief Technology & Operations OfficerPrecision fermentationSweden
Chief R&D OfficerMitochondrial medicineUK
VP, Head of BiometricsOncology drug developmentUS
VP, CMC & DevelopmentT-cell technologiesUK
Head of RegulatorySmall molecule inhibitorsUS
Global Marketing Director BiosurgerySurgical technologiesUS
General Manager FranceRemote patient monitoringUK/ France
Head of Hospitals & Value AccessOphthalmology therapeuticsItaly
Senior Executive Director, TranslationalRadiopharmaceuticalsUS
Senior Director, New Ventures and InvestmentsUniversity incubator/ acceleratorAustralia

Newly opened projects include:

FunctionFocus areaLocation
CEOBio-storage solutionsUK
Chief Financial OfficerCardiac devicesFrance
Chief Scientific OfficertRNA platformUS
Chief Operating OfficerMedical devicesUK
Chief Business OfficerAI-enabled imagingSpain
Chief Scientific OfficerNeuropsychiatryUS
Head of Sales and MarketingSpecialty pharmaUK
Country CEOHealthcare servicesFrance
International Commercial DirectorSpecialty pharmaUK
Board DirectorOncology pharmaAustralia
Board DirectorAntibody platformCanada
ChairHealthtechBelgium
Fund Managing PartnerLife sciences research institutionUK

Read the Press Release